FISCAL NOTE
Date Requested: February 11, 2020 Time Requested: 03:56 PM |
Agency: |
Health and Human Resources, WV Department of |
CBD Number: |
Version: |
Bill Number: |
Resolution Number: |
2724 |
Introduced |
HB4583 |
|
CBD Subject: |
Health |
---|
|
FUND(S):
0403 - DIV OF HUMAN SERVICES GENERAL ADMINISTRATION FUND, 8722 - CONS FEDERAL FUNDS DIV HUMAN SERVICES GEN ADMN FD
Sources of Revenue:
General Fund Federal
Legislation creates:
Fiscal Note Summary
Effect this measure will have on costs and revenues of state government.
The purpose of this bill is to require drug manufacturers and health benefit plan issuers who sell prescription drugs in West Virginia to provide cost information, changes in cost information, and prescription drug statistics to the State Auditor. The bill requires the Auditor to publish this information on a searchable transparency website available to the public and disclose identities of drug manufacturers and health benefit plan issuers who fail to comply with the requirements of the article.
The Department does not anticipate issues complying with the proposed legislation. Any anticipated costs could be absorbed within current budget.
The Bureau for Medical Services, Office of Pharmacy would be responsible for obtaining, verifying and maintaining the data. This would be done by analyzing reports from claims processing vendor (DXC), similar to the current process used for drug utilization review.
Fiscal Note Detail
Effect of Proposal |
Fiscal Year |
2020 Increase/Decrease (use"-") |
2021 Increase/Decrease (use"-") |
Fiscal Year (Upon Full Implementation) |
1. Estmated Total Cost |
0 |
0 |
0 |
Personal Services |
0 |
0 |
0 |
Current Expenses |
0 |
0 |
0 |
Repairs and Alterations |
0 |
0 |
0 |
Assets |
0 |
0 |
0 |
Other |
0 |
0 |
0 |
2. Estimated Total Revenues |
0 |
0 |
0 |
Explanation of above estimates (including long-range effect):
Please explain increases and decreases in personal services, current expenses, repairs and alterations, assets, other costs and revenues, including assumptions and data sources and delineation between start-up and ongoing costs. Please also include a long-range schedule of costs and revenues if fiscal impact is expected to vary in future years.
Memorandum
The bill, as introduced, does not contemplate the Department's current carve-out of the point of sale drug benefit from managed care. However, if passed in this form, the Department would still do its best to comply with the spirit of the bill in meeting the requirements of section 4. However, items 3 and 5, would not be applicable, as premiums are not paid to cover these expenditures. The items referencing “plans” would be provided with respect to the whole Medicaid Program.
Person submitting Fiscal Note: Bill J. Crouch
Email Address: dhhrbudgetoffice@wv.gov